1 Study Coverage
    1.1 Adalimumab Product Introduction
    1.2 Market by Type
        1.2.1 Global Adalimumab Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Adalimumab
        1.2.3 Adalimumab Biosimilar
    1.3 Market by Application
        1.3.1 Global Adalimumab Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Adults
        1.3.3 Children
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Adalimumab Sales Estimates and Forecasts 2017-2028
    2.2 Global Adalimumab Revenue Estimates and Forecasts 2017-2028
    2.3 Global Adalimumab Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Adalimumab Sales by Region
        2.4.1 Global Adalimumab Sales by Region (2017-2022)
        2.4.2 Global Sales Adalimumab by Region (2023-2028)
    2.5 Global Adalimumab Revenue by Region
        2.5.1 Global Adalimumab Revenue by Region (2017-2022)
        2.5.2 Global Adalimumab Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Adalimumab Sales by Manufacturers
        3.1.1 Global Top Adalimumab Manufacturers by Sales (2017-2022)
        3.1.2 Global Adalimumab Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Adalimumab in 2021
    3.2 Global Adalimumab Revenue by Manufacturers
        3.2.1 Global Adalimumab Revenue by Manufacturers (2017-2022)
        3.2.2 Global Adalimumab Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Adalimumab Revenue in 2021
    3.3 Global Adalimumab Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Adalimumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Adalimumab Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Adalimumab Sales by Type
        4.1.1 Global Adalimumab Historical Sales by Type (2017-2022)
        4.1.2 Global Adalimumab Forecasted Sales by Type (2023-2028)
        4.1.3 Global Adalimumab Sales Market Share by Type (2017-2028)
    4.2 Global Adalimumab Revenue by Type
        4.2.1 Global Adalimumab Historical Revenue by Type (2017-2022)
        4.2.2 Global Adalimumab Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Adalimumab Revenue Market Share by Type (2017-2028)
    4.3 Global Adalimumab Price by Type
        4.3.1 Global Adalimumab Price by Type (2017-2022)
        4.3.2 Global Adalimumab Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Adalimumab Sales by Application
        5.1.1 Global Adalimumab Historical Sales by Application (2017-2022)
        5.1.2 Global Adalimumab Forecasted Sales by Application (2023-2028)
        5.1.3 Global Adalimumab Sales Market Share by Application (2017-2028)
    5.2 Global Adalimumab Revenue by Application
        5.2.1 Global Adalimumab Historical Revenue by Application (2017-2022)
        5.2.2 Global Adalimumab Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Adalimumab Revenue Market Share by Application (2017-2028)
    5.3 Global Adalimumab Price by Application
        5.3.1 Global Adalimumab Price by Application (2017-2022)
        5.3.2 Global Adalimumab Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Adalimumab Market Size by Type
        6.1.1 North America Adalimumab Sales by Type (2017-2028)
        6.1.2 North America Adalimumab Revenue by Type (2017-2028)
    6.2 North America Adalimumab Market Size by Application
        6.2.1 North America Adalimumab Sales by Application (2017-2028)
        6.2.2 North America Adalimumab Revenue by Application (2017-2028)
    6.3 North America Adalimumab Market Size by Country
        6.3.1 North America Adalimumab Sales by Country (2017-2028)
        6.3.2 North America Adalimumab Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Adalimumab Market Size by Type
        7.1.1 Europe Adalimumab Sales by Type (2017-2028)
        7.1.2 Europe Adalimumab Revenue by Type (2017-2028)
    7.2 Europe Adalimumab Market Size by Application
        7.2.1 Europe Adalimumab Sales by Application (2017-2028)
        7.2.2 Europe Adalimumab Revenue by Application (2017-2028)
    7.3 Europe Adalimumab Market Size by Country
        7.3.1 Europe Adalimumab Sales by Country (2017-2028)
        7.3.2 Europe Adalimumab Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Adalimumab Market Size by Type
        8.1.1 Asia Pacific Adalimumab Sales by Type (2017-2028)
        8.1.2 Asia Pacific Adalimumab Revenue by Type (2017-2028)
    8.2 Asia Pacific Adalimumab Market Size by Application
        8.2.1 Asia Pacific Adalimumab Sales by Application (2017-2028)
        8.2.2 Asia Pacific Adalimumab Revenue by Application (2017-2028)
    8.3 Asia Pacific Adalimumab Market Size by Region
        8.3.1 Asia Pacific Adalimumab Sales by Region (2017-2028)
        8.3.2 Asia Pacific Adalimumab Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Adalimumab Market Size by Type
        9.1.1 Latin America Adalimumab Sales by Type (2017-2028)
        9.1.2 Latin America Adalimumab Revenue by Type (2017-2028)
    9.2 Latin America Adalimumab Market Size by Application
        9.2.1 Latin America Adalimumab Sales by Application (2017-2028)
        9.2.2 Latin America Adalimumab Revenue by Application (2017-2028)
    9.3 Latin America Adalimumab Market Size by Country
        9.3.1 Latin America Adalimumab Sales by Country (2017-2028)
        9.3.2 Latin America Adalimumab Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Adalimumab Market Size by Type
        10.1.1 Middle East and Africa Adalimumab Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Adalimumab Revenue by Type (2017-2028)
    10.2 Middle East and Africa Adalimumab Market Size by Application
        10.2.1 Middle East and Africa Adalimumab Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Adalimumab Revenue by Application (2017-2028)
    10.3 Middle East and Africa Adalimumab Market Size by Country
        10.3.1 Middle East and Africa Adalimumab Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Adalimumab Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 AbbVie
        11.1.1 AbbVie Corporation Information
        11.1.2 AbbVie Overview
        11.1.3 AbbVie Adalimumab Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 AbbVie Adalimumab Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 AbbVie Recent Developments
    11.2 Amgen
        11.2.1 Amgen Corporation Information
        11.2.2 Amgen Overview
        11.2.3 Amgen Adalimumab Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Amgen Adalimumab Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Amgen Recent Developments
    11.3 Sandoz
        11.3.1 Sandoz Corporation Information
        11.3.2 Sandoz Overview
        11.3.3 Sandoz Adalimumab Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Sandoz Adalimumab Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Sandoz Recent Developments
    11.4 Boehringer Ingelheim
        11.4.1 Boehringer Ingelheim Corporation Information
        11.4.2 Boehringer Ingelheim Overview
        11.4.3 Boehringer Ingelheim Adalimumab Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Boehringer Ingelheim Adalimumab Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Boehringer Ingelheim Recent Developments
    11.5 Mylan
        11.5.1 Mylan Corporation Information
        11.5.2 Mylan Overview
        11.5.3 Mylan Adalimumab Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Mylan Adalimumab Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Mylan Recent Developments
    11.6 Biogen
        11.6.1 Biogen Corporation Information
        11.6.2 Biogen Overview
        11.6.3 Biogen Adalimumab Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Biogen Adalimumab Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Biogen Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Adalimumab Industry Chain Analysis
    12.2 Adalimumab Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Adalimumab Production Mode & Process
    12.4 Adalimumab Sales and Marketing
        12.4.1 Adalimumab Sales Channels
        12.4.2 Adalimumab Distributors
    12.5 Adalimumab Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Adalimumab Industry Trends
    13.2 Adalimumab Market Drivers
    13.3 Adalimumab Market Challenges
    13.4 Adalimumab Market Restraints
14 Key Findings in The Global Adalimumab Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Adalimumab Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Adalimumab
    Table 3. Major Manufacturers of Adalimumab Biosimilar
    Table 4. Global Adalimumab Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Adalimumab Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Adalimumab Sales by Region (2017-2022) & (K Units)
    Table 7. Global Adalimumab Sales Market Share by Region (2017-2022)
    Table 8. Global Adalimumab Sales by Region (2023-2028) & (K Units)
    Table 9. Global Adalimumab Sales Market Share by Region (2023-2028)
    Table 10. Global Adalimumab Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Adalimumab Revenue Market Share by Region (2017-2022)
    Table 12. Global Adalimumab Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Adalimumab Revenue Market Share by Region (2023-2028)
    Table 14. Global Adalimumab Sales by Manufacturers (2017-2022) & (K Units)
    Table 15. Global Adalimumab Sales Share by Manufacturers (2017-2022)
    Table 16. Global Adalimumab Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Adalimumab Revenue Share by Manufacturers (2017-2022)
    Table 18. Adalimumab Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 19. Global Adalimumab Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Adalimumab by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adalimumab as of 2021)
    Table 21. Adalimumab Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Adalimumab Product Offered
    Table 23. Date of Manufacturers Enter into Adalimumab Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Adalimumab Sales by Type (2017-2022) & (K Units)
    Table 26. Global Adalimumab Sales by Type (2023-2028) & (K Units)
    Table 27. Global Adalimumab Sales Share by Type (2017-2022)
    Table 28. Global Adalimumab Sales Share by Type (2023-2028)
    Table 29. Global Adalimumab Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Adalimumab Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Adalimumab Revenue Share by Type (2017-2022)
    Table 32. Global Adalimumab Revenue Share by Type (2023-2028)
    Table 33. Adalimumab Price by Type (2017-2022) & (USD/Unit)
    Table 34. Global Adalimumab Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 35. Global Adalimumab Sales by Application (2017-2022) & (K Units)
    Table 36. Global Adalimumab Sales by Application (2023-2028) & (K Units)
    Table 37. Global Adalimumab Sales Share by Application (2017-2022)
    Table 38. Global Adalimumab Sales Share by Application (2023-2028)
    Table 39. Global Adalimumab Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Adalimumab Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Adalimumab Revenue Share by Application (2017-2022)
    Table 42. Global Adalimumab Revenue Share by Application (2023-2028)
    Table 43. Adalimumab Price by Application (2017-2022) & (USD/Unit)
    Table 44. Global Adalimumab Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 45. North America Adalimumab Sales by Type (2017-2022) & (K Units)
    Table 46. North America Adalimumab Sales by Type (2023-2028) & (K Units)
    Table 47. North America Adalimumab Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Adalimumab Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Adalimumab Sales by Application (2017-2022) & (K Units)
    Table 50. North America Adalimumab Sales by Application (2023-2028) & (K Units)
    Table 51. North America Adalimumab Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Adalimumab Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Adalimumab Sales by Country (2017-2022) & (K Units)
    Table 54. North America Adalimumab Sales by Country (2023-2028) & (K Units)
    Table 55. North America Adalimumab Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Adalimumab Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Adalimumab Sales by Type (2017-2022) & (K Units)
    Table 58. Europe Adalimumab Sales by Type (2023-2028) & (K Units)
    Table 59. Europe Adalimumab Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Adalimumab Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Adalimumab Sales by Application (2017-2022) & (K Units)
    Table 62. Europe Adalimumab Sales by Application (2023-2028) & (K Units)
    Table 63. Europe Adalimumab Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Adalimumab Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Adalimumab Sales by Country (2017-2022) & (K Units)
    Table 66. Europe Adalimumab Sales by Country (2023-2028) & (K Units)
    Table 67. Europe Adalimumab Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Adalimumab Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Adalimumab Sales by Type (2017-2022) & (K Units)
    Table 70. Asia Pacific Adalimumab Sales by Type (2023-2028) & (K Units)
    Table 71. Asia Pacific Adalimumab Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Adalimumab Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Adalimumab Sales by Application (2017-2022) & (K Units)
    Table 74. Asia Pacific Adalimumab Sales by Application (2023-2028) & (K Units)
    Table 75. Asia Pacific Adalimumab Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Adalimumab Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Adalimumab Sales by Region (2017-2022) & (K Units)
    Table 78. Asia Pacific Adalimumab Sales by Region (2023-2028) & (K Units)
    Table 79. Asia Pacific Adalimumab Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Adalimumab Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Adalimumab Sales by Type (2017-2022) & (K Units)
    Table 82. Latin America Adalimumab Sales by Type (2023-2028) & (K Units)
    Table 83. Latin America Adalimumab Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Adalimumab Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Adalimumab Sales by Application (2017-2022) & (K Units)
    Table 86. Latin America Adalimumab Sales by Application (2023-2028) & (K Units)
    Table 87. Latin America Adalimumab Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Adalimumab Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Adalimumab Sales by Country (2017-2022) & (K Units)
    Table 90. Latin America Adalimumab Sales by Country (2023-2028) & (K Units)
    Table 91. Latin America Adalimumab Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Adalimumab Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Adalimumab Sales by Type (2017-2022) & (K Units)
    Table 94. Middle East and Africa Adalimumab Sales by Type (2023-2028) & (K Units)
    Table 95. Middle East and Africa Adalimumab Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Adalimumab Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Adalimumab Sales by Application (2017-2022) & (K Units)
    Table 98. Middle East and Africa Adalimumab Sales by Application (2023-2028) & (K Units)
    Table 99. Middle East and Africa Adalimumab Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Adalimumab Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Adalimumab Sales by Country (2017-2022) & (K Units)
    Table 102. Middle East and Africa Adalimumab Sales by Country (2023-2028) & (K Units)
    Table 103. Middle East and Africa Adalimumab Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Adalimumab Revenue by Country (2023-2028) & (US$ Million)
    Table 105. AbbVie Corporation Information
    Table 106. AbbVie Description and Major Businesses
    Table 107. AbbVie Adalimumab Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 108. AbbVie Adalimumab Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. AbbVie Recent Developments
    Table 110. Amgen Corporation Information
    Table 111. Amgen Description and Major Businesses
    Table 112. Amgen Adalimumab Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 113. Amgen Adalimumab Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Amgen Recent Developments
    Table 115. Sandoz Corporation Information
    Table 116. Sandoz Description and Major Businesses
    Table 117. Sandoz Adalimumab Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 118. Sandoz Adalimumab Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Sandoz Recent Developments
    Table 120. Boehringer Ingelheim Corporation Information
    Table 121. Boehringer Ingelheim Description and Major Businesses
    Table 122. Boehringer Ingelheim Adalimumab Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 123. Boehringer Ingelheim Adalimumab Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Boehringer Ingelheim Recent Developments
    Table 125. Mylan Corporation Information
    Table 126. Mylan Description and Major Businesses
    Table 127. Mylan Adalimumab Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 128. Mylan Adalimumab Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Mylan Recent Developments
    Table 130. Biogen Corporation Information
    Table 131. Biogen Description and Major Businesses
    Table 132. Biogen Adalimumab Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 133. Biogen Adalimumab Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Biogen Recent Developments
    Table 135. Key Raw Materials Lists
    Table 136. Raw Materials Key Suppliers Lists
    Table 137. Adalimumab Distributors List
    Table 138. Adalimumab Customers List
    Table 139. Adalimumab Market Trends
    Table 140. Adalimumab Market Drivers
    Table 141. Adalimumab Market Challenges
    Table 142. Adalimumab Market Restraints
    Table 143. Research Programs/Design for This Report
    Table 144. Key Data Information from Secondary Sources
    Table 145. Key Data Information from Primary Sources
List of Figures
    Figure 1. Adalimumab Product Picture
    Figure 3. Global Adalimumab Market Share by Type in 2021 & 2028
    Figure 3. Adalimumab Product Picture
    Figure 4. Adalimumab Biosimilar Product Picture
    Figure 5. Global Adalimumab Market Share by Application in 2021 & 2028
    Figure 6. Adults
    Figure 7. Children
    Figure 8. Adalimumab Report Years Considered
    Figure 9. Global Adalimumab Sales 2017-2028 (K Units)
    Figure 10. Global Adalimumab Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Adalimumab Revenue 2017-2028 (US$ Million)
    Figure 12. Global Adalimumab Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 13. Global Adalimumab Sales Market Share by Region (2017-2022)
    Figure 14. Global Adalimumab Sales Market Share by Region (2023-2028)
    Figure 15. North America Adalimumab Sales YoY (2017-2028) & (K Units)
    Figure 16. North America Adalimumab Revenue YoY (2017-2028) & (US$ Million)
    Figure 17. Europe Adalimumab Sales YoY (2017-2028) & (K Units)
    Figure 18. Europe Adalimumab Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Asia-Pacific Adalimumab Sales YoY (2017-2028) & (K Units)
    Figure 20. Asia-Pacific Adalimumab Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Latin America Adalimumab Sales YoY (2017-2028) & (K Units)
    Figure 22. Latin America Adalimumab Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Middle East & Africa Adalimumab Sales YoY (2017-2028) & (K Units)
    Figure 24. Middle East & Africa Adalimumab Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. The Adalimumab Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 26. The Top 5 and 10 Largest Manufacturers of Adalimumab in the World: Market Share by Adalimumab Revenue in 2021
    Figure 27. Global Adalimumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 28. Global Adalimumab Sales Market Share by Type (2017-2028)
    Figure 29. Global Adalimumab Revenue Market Share by Type (2017-2028)
    Figure 30. Global Adalimumab Sales Market Share by Application (2017-2028)
    Figure 31. Global Adalimumab Revenue Market Share by Application (2017-2028)
    Figure 32. North America Adalimumab Sales Market Share by Type (2017-2028)
    Figure 33. North America Adalimumab Revenue Market Share by Type (2017-2028)
    Figure 34. North America Adalimumab Sales Market Share by Application (2017-2028)
    Figure 35. North America Adalimumab Revenue Market Share by Application (2017-2028)
    Figure 36. North America Adalimumab Sales Share by Country (2017-2028)
    Figure 37. North America Adalimumab Revenue Share by Country (2017-2028)
    Figure 38. U.S. Adalimumab Revenue (2017-2028) & (US$ Million)
    Figure 39. Canada Adalimumab Revenue (2017-2028) & (US$ Million)
    Figure 40. Europe Adalimumab Sales Market Share by Type (2017-2028)
    Figure 41. Europe Adalimumab Revenue Market Share by Type (2017-2028)
    Figure 42. Europe Adalimumab Sales Market Share by Application (2017-2028)
    Figure 43. Europe Adalimumab Revenue Market Share by Application (2017-2028)
    Figure 44. Europe Adalimumab Sales Share by Country (2017-2028)
    Figure 45. Europe Adalimumab Revenue Share by Country (2017-2028)
    Figure 46. Germany Adalimumab Revenue (2017-2028) & (US$ Million)
    Figure 47. France Adalimumab Revenue (2017-2028) & (US$ Million)
    Figure 48. U.K. Adalimumab Revenue (2017-2028) & (US$ Million)
    Figure 49. Italy Adalimumab Revenue (2017-2028) & (US$ Million)
    Figure 50. Russia Adalimumab Revenue (2017-2028) & (US$ Million)
    Figure 51. Asia Pacific Adalimumab Sales Market Share by Type (2017-2028)
    Figure 52. Asia Pacific Adalimumab Revenue Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Adalimumab Sales Market Share by Application (2017-2028)
    Figure 54. Asia Pacific Adalimumab Revenue Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Adalimumab Sales Share by Region (2017-2028)
    Figure 56. Asia Pacific Adalimumab Revenue Share by Region (2017-2028)
    Figure 57. China Adalimumab Revenue (2017-2028) & (US$ Million)
    Figure 58. Japan Adalimumab Revenue (2017-2028) & (US$ Million)
    Figure 59. South Korea Adalimumab Revenue (2017-2028) & (US$ Million)
    Figure 60. India Adalimumab Revenue (2017-2028) & (US$ Million)
    Figure 61. Australia Adalimumab Revenue (2017-2028) & (US$ Million)
    Figure 62. Taiwan Adalimumab Revenue (2017-2028) & (US$ Million)
    Figure 63. Indonesia Adalimumab Revenue (2017-2028) & (US$ Million)
    Figure 64. Thailand Adalimumab Revenue (2017-2028) & (US$ Million)
    Figure 65. Malaysia Adalimumab Revenue (2017-2028) & (US$ Million)
    Figure 66. Philippines Adalimumab Revenue (2017-2028) & (US$ Million)
    Figure 67. Latin America Adalimumab Sales Market Share by Type (2017-2028)
    Figure 68. Latin America Adalimumab Revenue Market Share by Type (2017-2028)
    Figure 69. Latin America Adalimumab Sales Market Share by Application (2017-2028)
    Figure 70. Latin America Adalimumab Revenue Market Share by Application (2017-2028)
    Figure 71. Latin America Adalimumab Sales Share by Country (2017-2028)
    Figure 72. Latin America Adalimumab Revenue Share by Country (2017-2028)
    Figure 73. Mexico Adalimumab Revenue (2017-2028) & (US$ Million)
    Figure 74. Brazil Adalimumab Revenue (2017-2028) & (US$ Million)
    Figure 75. Argentina Adalimumab Revenue (2017-2028) & (US$ Million)
    Figure 76. Middle East and Africa Adalimumab Sales Market Share by Type (2017-2028)
    Figure 77. Middle East and Africa Adalimumab Revenue Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Adalimumab Sales Market Share by Application (2017-2028)
    Figure 79. Middle East and Africa Adalimumab Revenue Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Adalimumab Sales Share by Country (2017-2028)
    Figure 81. Middle East and Africa Adalimumab Revenue Share by Country (2017-2028)
    Figure 82. Turkey Adalimumab Revenue (2017-2028) & (US$ Million)
    Figure 83. Saudi Arabia Adalimumab Revenue (2017-2028) & (US$ Million)
    Figure 84. U.A.E Adalimumab Revenue (2017-2028) & (US$ Million)
    Figure 85. Adalimumab Value Chain
    Figure 86. Adalimumab Production Process
    Figure 87. Channels of Distribution
    Figure 88. Distributors Profiles
    Figure 89. Bottom-up and Top-down Approaches for This Report
    Figure 90. Data Triangulation
    Figure 91. Key Executives Interviewed